Project Details
Description
A Phase 1B, Randomized, Placebo Controlled, Multiple Dose Study to Evaluate the Safety of Intravenous Infusion of Human Placenta-Derived Cells (PDA001) for the Treatment of Adults with Multiple Sclerosis
| Status | Finished |
|---|---|
| Effective start/end date | 12/1/10 → 11/30/13 |
Funding
- CELGENE CORPORATION
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.